Intraocular Melanoma

Showing 1 - 25 of 33

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)

Active, not recruiting
  • Brain and Central Nervous System Tumors
  • +9 more
  • DNA analysis
  • +4 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 28, 2021

Intraocular Melanoma, Melanoma (Skin), Metastatic Cancer Trial in United States (melphalan, regional chemo, systemic chemo)

Completed
  • Intraocular Melanoma
  • +2 more
  • Santa Monica, California
  • +11 more
Jun 15, 2021

Acral Lentiginous Malignant Melanoma, Ciliary Body and Choroid Melanoma, Medium/Large Size, Ciliary Body and Choroid Melanoma,

Completed
  • Acral Lentiginous Malignant Melanoma
  • +10 more
  • cediranib maleate
  • Toronto, Ontario, Canada
    Princess Margaret Hospital Phase 2 Consortium
Jul 27, 2018

Intraocular Melanoma, Malignant Conjunctival Tumor, Melanoma (Skin) Trial in Pittsburgh (Peptide vaccine, GM-CSF, PF3512676)

Completed
  • Intraocular Melanoma
  • +2 more
  • Peptide vaccine
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Cancer Centers
Jun 21, 2017

Intraocular Melanoma, Malignant Conjunctival Tumor Trial run by the CC (cyclophosphamide, lenalidomide, sunitinib malate)

Terminated
  • Intraocular Melanoma
  • Malignant Conjunctival Neoplasm
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
Feb 6, 2017

Intraocular Melanoma, Melanoma (Skin) Trial in New York (biological, device, other)

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • mouse gp100 plasmid DNA vaccine
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jan 26, 2017

Intraocular Melanoma, Malignant Conjunctival Tumor, Melanoma (Skin) Trial in Charlottesville (incomplete Freund's adjuvant,

Completed
  • Intraocular Melanoma
  • +2 more
  • incomplete Freund's adjuvant
  • +3 more
  • Charlottesville, Virginia
    University of Virginia Cancer Center
Dec 15, 2016

Intraocular Melanoma Trial in Columbus (nab-paclitaxel)

Completed
  • Intraocular Melanoma
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jan 14, 2016

Tumor Samples in Patients Undergoing Radiation Therapy or

Completed
  • Intraocular Melanoma
  • fluorescence in situ hybridization
  • +4 more
  • Cleveland, Ohio
    Cleveland Clinic Cole Eye Institute
Jan 28, 2015

Intraocular Melanoma, Melanoma (Skin) Trial in Charlottesville (incomplete Freund's adjuvant, multi-epitope melanoma peptide

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • incomplete Freund's adjuvant
  • +2 more
  • Charlottesville, Virginia
    Cancer Center at the University of Virginia
Dec 18, 2014

Intraocular Melanoma, Melanoma (Skin) Trial in Charlottesville (IFA, 6MHP, GM-CSF)

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • IFA
  • +2 more
  • Charlottesville, Virginia
    University of Virginia Cancer Center
Nov 18, 2014

Brain and CNS Tumors, Childhood Langerhans Cell Histiocytosis, Gastrointestinal Carcinoid Tumor Trial in New Haven (indium In

Terminated
  • Brain and Central Nervous System Tumors
  • +11 more
  • indium In 111 pentetreotide
  • New Haven, Connecticut
    Yale Comprehensive Cancer Center
Jul 1, 2014

Intraocular Melanoma, Melanoma (Skin) Trial in Los Angeles (MART-1 antigen, gp100 antigen, incomplete Freund's adjuvant)

Terminated
  • Intraocular Melanoma
  • Melanoma (Skin)
  • MART-1 antigen
  • +4 more
  • Los Angeles, California
  • +1 more
May 20, 2014

Intraocular Melanoma, Melanoma (Skin) Trial in Duarte, Los Angeles (gp100 antigen, incomplete Freund's adjuvant, recombinant

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • gp100 antigen
  • +3 more
  • Duarte, California
  • +1 more
May 20, 2014

Intraocular Melanoma, Melanoma (Skin) Trial in Los Angeles (biological, drug, procedure)

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • MART-1 antigen
  • +7 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center and Hospital
May 20, 2014

Intraocular Melanoma, Melanoma (Skin) Trial in Los Angeles (MART-1 antigen, gp100 antigen, incomplete Freund's adjuvant)

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • MART-1 antigen
  • +5 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center and Hospital
May 20, 2014

Intraocular Melanoma, Melanoma (Skin) Trial in Los Angeles, Ann Arbor (MART-1 antigen, gp100:209-217(210M) peptide vaccine,

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • MART-1 antigen
  • +3 more
  • Los Angeles, California
  • +1 more
May 19, 2014

Intraocular Melanoma, Melanoma (Skin) Trial in Tampa (Autologous Dendritic Cells (DC), Fludarabine, Autologous Lymphocyte

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • Autologous Dendritic Cells (DC)
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Feb 20, 2014

Intraocular Melanoma Trial in Encinitas (cisplatin, sunitinib malate, tamoxifen citrate)

Unknown status
  • Intraocular Melanoma
  • Encinitas, California
    San Diego Pacific Oncology and Hematology Associates, Incorporat
Jan 9, 2014

Genes and Environment in Cancer in East Anglia, Trent, or West

Unknown status
  • Bladder Cancer
  • +8 more
  • DNA analysis
  • +3 more
  • Cambridge, England, United Kingdom
    University of Cambridge Cancer Research UK
Aug 23, 2013

Intraocular Melanoma Trial in Paris (biological, drug, genetic, other)

Unknown status
  • Intraocular Melanoma
  • bevacizumab
  • +3 more
  • Paris, France
    Institut Curie Hopital
Aug 23, 2013

Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (iodine I 131 mAb 3F8)

Completed
  • Brain and Central Nervous System Tumors
  • +6 more
  • iodine I 131 monoclonal antibody 3F8
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jul 1, 2013

Intraocular Melanoma, Melanoma (Skin) Trial run by the NCI (gp100 antigen, incomplete Freund's adjuvant, ipilimumab)

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • gp100 antigen
  • +2 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013

Intraocular Melanoma, Melanoma (Skin) Trial run by the NCI (aldesleukin, ipilimumab)

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • aldesleukin
  • ipilimumab
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013

Intraocular Melanoma, Melanoma (Skin) Trial in New York (temozolomide, thalidomide)

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 17, 2013